Fortis Healthcare Limited

FORTIS

INE061F01013

Healthcare Facilities & Services

Market Closed - NSE India S.E. Other stock markets 05:19:36 06/12/2024 pm IST			5-day change	1st Jan Change
714.25 ^INR	+2.93%		+8.35%	+70.38%

12/11	Nomura Adjusts Fortis Healthcare's Price Target to INR700 From INR547, Keeps at Buy	MT
11/11	Jefferies Adjusts Fortis Healthcare's Price Target to INR725 From INR575, Keeps at Buy	MT

This article is reserved for members

To unlock the article, REGISTER!

100% Free Registration

Already a customer? Log In

Latest news about Fortis Healthcare Limited

Nomura Adjusts Fortis Healthcare's Price Target to INR700 From INR547, Keeps at Buy	12/11	MT
Jefferies Adjusts Fortis Healthcare's Price Target to INR725 From INR575, Keeps at Buy	11/11	MT
Fortis Healthcare Seeks Acquisitions	08/11	CI
Fortis Healthcare Limited, Q2 2025 Earnings Call, Nov 08, 2024	08/11
Fortis Healthcare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024	08/11	CI
Fortis Healthcare Gets Board Nod to Raise Up To INR15.5 Billion	10/10	MT
Fortis Healthcare Limited Appoints Indrajit Banerjee, as Chairman of the Audit Committee and A Member of the Nomination & Remuneration Committee, Stakeholder Relationship Committee and Corporate Social Responsibility Committee, Effective October 1, 2024	23/09	CI
IHH Healthcare Updates on Tokyo Court Case Over Fortis Acquisition	22/08	MT
Jefferies Adjusts Fortis Healthcare's Price Target to INR575 From INR545, Keeps at Buy	08/08	MT
Fortis Healthcare Limited agreed to acquire remaining 31.52% stake in Agilus Diagnostics Limited.	08/08	CI
Fortis Healthcare Reportedly to Buy Out PE Funds from Diagnostics Arm Agilus	08/08	CI
Fortis Healthcare's Consolidated Profit Rises in Fiscal Q1	07/08	MT
Fortis Healthcare Limited, Q1 2025 Earnings Call, Aug 07, 2024	07/08
Fortis Healthcare Chairman Steps Down	07/08	MT
India's Fortis Healthcare chairman Ravi Rajagopal resigns	06/08	RE
Fortis Healthcare Limited Announces Resignation of Ravi Rajagopal as Chairman and Non- Executive Independent Director, with Effect from Closing Hours on September 30, 2024	06/08	CI
Fortis Healthcare Limited Reports Earnings Results for the First Quarter Ended June 30, 2024	06/08	CI
India's Aster DM Healthcare's Q1 profit rises on strong flu season-led demand	31/07	RE
Nomura Adjusts Fortis Healthcare's Price Target to INR547 From INR475, Keeps at Buy	16/07	MT
Fortis Healthcare Limited Designates Prem Kumar Nair as Vice-Chairman of Board	05/07	CI
Fortis, Apollo, Medanta, and Max Lead the Charge in Bidding War for Jaypee Healthcare	17/06	CI
Fortis Healthcare Limited Announces Executive Appointments	11/06	CI
Matrimony.com Names Former Fortis Executive as Human Resources Chief	11/06	MT
Jefferies Adjusts Fortis Healthcare’s Price Target to INR545 From INR510, Keeps at Buy	27/05	MT
Fortis Healthcare Limited, Q4 2024 Earnings Call, May 24, 2024	24/05

Chart Fortis Healthcare Limited

Duration

Period

FORTIS: Dynamic Chart

Fortis Healthcare Limited is an India-based integrated healthcare delivery service provider. The Company is primarily engaged in the business of healthcare services. The Company operates through healthcare services segment. Its specialties include cardiac sciences, cosmetology, dental sciences, dermatology, general surgery, oncology, pulmonology, urology, neurosurgery, radiology, orthopedics, and organ transplant, among others. It manages and operates a network of multi-specialty hospitals and diagnostics centers. The healthcare verticals of the Company primarily consist of hospitals, diagnostics, and day care specialty facilities. It has approximately 27 healthcare facilities, including projects under development, 4500 operational beds and over 400 diagnostics centers. It operates in India, United Arab Emirates and Sri Lanka. Its subsidiaries include Escorts Heart Institute and Research Centre Limited, Fortis Health staff Limited, and Fortis Asia Healthcare Pte. Ltd, among others.

Employees

12,088

Sector

Healthcare Facilities & Services

Calendar

07/02/2025 - Q3 2025 Earnings Release (Projected)

More about the company